On July 9, 2019, WHO updated its model list of essential medicines to include oral ivermectin for ectoparasitic infections.1 This recommendation follows the 2017 WHO categorisation of scabies as a neglected tropical disease. The list covers the “minimum medicine needs for a basic health-care system, listing the most efficacious, safe and cost-effective medicines for priority conditions”.1 In the UK, scabies outbreaks are a substantial public health burden in care homes for older people
